Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Keywords » - entrée « Time Factors (MeSH) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Time (MeSH) < Time Factors (MeSH) < Time-to-Treatment (MeSH)  Facettes :

List of bibliographic references indexed by Time Factors (MeSH)

Number of relevant bibliographic references: 61.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000074 (2021) S Nia Romano [Portugal] ; Heloísa Galante [Portugal] ; Débora Figueira [Portugal] ; Zilda Mendes [Portugal] ; Ant Nio Teixeira Rodrigues [Portugal]Time-trend analysis of medicine sales and shortages during COVID-19 outbreak: Data from community pharmacies.
000121 (2021) Summary for Patients: Postexposure Hydroxychloroquine Prophylaxis to Prevent SARS-CoV-2 Infection.
000223 (2021) Jessica M. Franklin [États-Unis] ; Kueiyu Joshua Lin [États-Unis] ; Nicolle M. Gatto [États-Unis] ; Jeremy A. Rassen [États-Unis] ; Robert J. Glynn [États-Unis] ; Sebastian Schneeweiss [États-Unis]Real-World Evidence for Assessing Pharmaceutical Treatments in the Context of COVID-19.
000246 (2021) Jacobo Rogado [Espagne] ; Pedro Gull N [Espagne] ; Berta Obispo [Espagne] ; Gloria Serrano [Espagne] ; Miguel Lara [Espagne]Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors.
000353 (2021) Ji-Won Kim [Corée du Sud] ; Eun Jin Kim [Corée du Sud] ; Hyun Hee Kwon [Corée du Sud] ; Chi Young Jung [Corée du Sud] ; Kyung Chan Kim [Corée du Sud] ; Jung-Yoon Choe [Corée du Sud] ; Hyo-Lim Hong [Corée du Sud]Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019.
000424 (2021) Petri J. Vainio [Finlande] ; Pauliina Hietasalo [Finlande] ; Anna-Liisa Koivisto [Finlande] ; Susanna K Ri Inen [Finlande] ; Jari Turunen [Finlande] ; Mika Virtala [Finlande] ; Jouni Vuorinen [Finlande] ; Mika Scheinin [Finlande]Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
000444 (2021) Ruanne V. Barnabas ; Elizabeth R. Brown ; Anna Bershteyn ; Helen C. Stankiewicz Karita [États-Unis] ; Christine Johnston ; Lorna E. Thorpe ; Angelica Kottkamp ; Kathleen M. Neuzil ; Miriam K. Laufer ; Meagan Deming ; Michael K. Paasche-Orlow ; Patricia J. Kissinger ; Alfred Luk ; Kristopher Paolino ; Raphael J. Landovitz ; Risa Hoffman ; Torin T. Schaafsma [États-Unis] ; Meighan L. Krows [États-Unis] ; Katherine K. Thomas [États-Unis] ; Susan Morrison [États-Unis] ; Harald S. Haugen [États-Unis] ; Lara Kidoguchi [États-Unis] ; Mark Wener [États-Unis] ; Alexander L. Greninger ; Meei-Li Huang ; Keith R. Jerome ; Anna Wald ; Connie Celum [États-Unis] ; Helen Y. Chu [États-Unis] ; Jared M. Baeten [États-Unis]Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial.
000521 (2021) Daniela R. Junqueira [Canada] ; Brian H. Rowe [Canada]Efficacy and safety outcomes of proposed randomized controlled trials investigating hydroxychloroquine and chloroquine during the early stages of the COVID-19 pandemic.
000524 (2021) Amirreza Roostaei Firozabad [Iran] ; Zohreh Akhoundi Meybodi [Iran] ; Seyed Ruhollah Mousavinasab [Iran] ; Adeleh Sahebnasagh [Iran] ; Mohsen Gholinataj Jelodar [Iran] ; Iman Karimzadeh [Iran] ; Solomon Habtemariam [Royaume-Uni] ; Fatemeh Saghafi [Iran]Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial.
000547 (2021) Steven M. Smoke [États-Unis] ; Karan Raja [États-Unis] ; Patrick Hilden [États-Unis] ; Nicole M. Daniel [États-Unis]Early clinical outcomes with tocilizumab for severe COVID-19: a two-centre retrospective study.
000658 (2021) Geoffrey A. Rubin [États-Unis] ; Amar D. Desai [États-Unis] ; Zilan Chai [États-Unis] ; Aijin Wang [États-Unis] ; Qixuan Chen [États-Unis] ; Amy S. Wang [États-Unis] ; Cameron Kemal [États-Unis] ; Haajra Baksh [États-Unis] ; Angelo Biviano [États-Unis] ; Jose M. Dizon [États-Unis] ; Hirad Yarmohammadi [États-Unis] ; Frederick Ehlert [États-Unis] ; Deepak Saluja [États-Unis] ; David A. Rubin [États-Unis] ; John P. Morrow [États-Unis] ; Uma Mahesh R. Avula [États-Unis] ; Jeremy P. Berman [États-Unis] ; Alexander Kushnir [États-Unis] ; Mark P. Abrams [États-Unis] ; Jessica A. Hennessey [États-Unis] ; Pierre Elias [États-Unis] ; Timothy J. Poterucha [États-Unis] ; Nir Uriel [États-Unis] ; Christine J. Kubin [États-Unis] ; Elijah Lasota [États-Unis] ; Jason Zucker [États-Unis] ; Magdalena E. Sobieszczyk [États-Unis] ; Allan Schwartz [États-Unis] ; Hasan Garan [États-Unis] ; Marc P. Waase [États-Unis] ; Elaine Y. Wan [États-Unis]Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic.
000757 (2021) Michael Ewers [Allemagne] ; John P A. Ioannidis [États-Unis] ; Nikolaus Plesnila [Allemagne]Access to data from clinical trials in the COVID-19 crisis: open, flexible, and time-sensitive.
000846 (2020) Matthieu Million [France] ; Jean-Christophe Lagier [France] ; Philippe Gautret [France] ; Philippe Colson [France] ; Pierre-Edouard Fournier [France] ; Sophie Amrane [France] ; Marie Hocquart [France] ; Morgane Mailhe [France] ; Vera Esteves-Vieira [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Florian Correard [France] ; Audrey Giraud-Gatineau [France] ; Yanis Roussel [France] ; Cyril Berenger [France] ; Nadim Cassir [France] ; Piseth Seng [France] ; Christine Zandotti [France] ; Catherine Dhiver [France] ; Isabelle Ravaux [France] ; Christelle Tomei [France] ; Carole Eldin [France] ; Hervé Tissot-Dupont [France] ; Stéphane Honoré [France] ; Andreas Stein [France] ; Alexis Jacquier [France] ; Jean-Claude Deharo [France] ; Eric Chabrière [France] ; Anthony Levasseur [France] ; Florence Fenollar [France] ; Jean-Marc Rolain [France] ; Yolande Obadia [France] ; Philippe Brouqui [France] ; Michel Drancourt [France] ; Bernard La Scola [France] ; Philippe Parola [France] ; Didier Raoult [France]Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.
000924 (2020) Giovanni Mosconi [Italie] ; Alessandra Spazzoli [Italie] ; Paolo Ferdinando Bruno [Italie] ; Maria Laura Angelini [Italie] ; Stefania Cristino [Italie] ; Maria Francesca Lifrieri [Italie] ; Claudio Americo [Italie] ; Marco De Fabritiis [Italie] ; Katia Ambri [Italie] ; Giorgio Dirani [Italie] ; Simona Semprini [Italie] ; Vittorio Sambri [Italie] ; Loretta Zambianchi [Italie][Resilience in COVID-19 times: general considerations on the recovery of a 93-year-old patient on haemodialysis treatment].
000999 (2020) Donna Austin [Royaume-Uni] ; Catharine John [Royaume-Uni] ; Beverley J. Hunt [Royaume-Uni] ; Rachel S. Carling [Royaume-Uni]Validation of a liquid chromatography tandem mass spectrometry method for the simultaneous determination of hydroxychloroquine and metabolites in human whole blood.
000A08 (2020) Felix J F. Herth [Allemagne] ; George Sakoulas [Oman] ; Fadi Haddad [États-Unis]Use of Intravenous Immunoglobulin (Prevagen or Octagam) for the Treatment of COVID-19: Retrospective Case Series.
000A66 (2020) Timothy A. West [Australie] ; Sameer Malik [Australie] ; Anastasios Nalpantidis [Australie] ; Tuan Tran [Australie] ; Christine Cannon [Australie] ; Deepak Bhonagiri [Australie] ; Kevin Chan [Australie] ; Elaine Cheong [Australie] ; Jenny Wan Sai Cheong [Australie] ; Winston Cheung [Australie] ; Faisal Choudhury [Australie] ; David Ernest [Australie] ; Claude S. Farah [Australie] ; Shelanah Fernando [Australie] ; Rupa Kanapathipillai [Australie] ; Mark Kol [Australie] ; Brendan Murfin [Australie] ; Haider Naqvi [Australie] ; Asim Shah [Australie] ; Atul Wagh [Australie] ; Samar Ojaimi [Australie] ; Bradley Frankum [Australie] ; Sean Riminton [Australie] ; Karuna Keat [Australie]Tocilizumab for severe COVID-19 pneumonia: Case series of 5 Australian patients.
000B17 (2020) P. Mu Oz ; A. Galar [Espagne] ; P. Catalán ; M. Valerio ; T. Aldamiz-Echevarría ; C. C Lliga ; E. BouzaThe first 100 cases of COVID-19 in a Hospital in Madrid with a 2-month follow-up.
000B24 (2020) Heidi LedfordThe coronavirus outbreak could make it quicker and easier to trial drugs.
000B28 (2020) Luis Ayerbe [Royaume-Uni] ; Carlos Risco-Risco [Espagne] ; Salma Ayis [Royaume-Uni]The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients.
000B29 (2020) Luis Ayerbe [Royaume-Uni] ; Carlos Risco [Espagne] ; Salma Ayis [Royaume-Uni]The association between treatment with heparin and survival in patients with Covid-19.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Time Factors (MeSH)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Time Factors (MeSH)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Time Factors (MeSH)
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021